公开(公告)号：US08507676B2

公开(公告)日：2013-08-13

申请号：US13567386

申请日：2012-08-06

申请人： Miao Dai ,  Xingnian Fu ,  Feng He ,  Lei Jiang ,  Yue Li ,  Fang Liang ,  Lei Liu ,  Yuan Mi ,  Yao-Chang Xu ,  Guoliang Xun ,  Xiaoxia Yan ,  Zhengtian Yu ,  Ji Yue Zhang

发明人： Miao Dai ,  Xingnian Fu ,  Feng He ,  Lei Jiang ,  Yue Li ,  Fang Liang ,  Lei Liu ,  Yuan Mi ,  Yao-Chang Xu ,  Guoliang Xun ,  Xiaoxia Yan ,  Zhengtian Yu ,  Ji Yue Zhang

IPC分类号： C07D487/04 ,  C07D403/12 ,  A61K31/4985 ,  A61P35/00

CPC分类号： C07D471/04

摘要： The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).

摘要翻译： 本发明涉及式（I）的化合物及其盐：其中取代基如说明书中所定义; 用于治疗人或动物体的式（I）化合物，特别是关于c-Met酪氨酸激酶介导的疾病或病症; 使用式（I）化合物制备用于治疗这些疾病的药物; 包含式（I）化合物，任选在组合配偶体存在下的药物组合物，以及制备式（I）化合物的方法。

公开(公告)号：US08410264B2

公开(公告)日：2013-04-02

申请号：US12859653

申请日：2010-08-19

申请人： Miao Dai ,  Xingnian Fu ,  Feng He ,  Lei Jiang ,  Yue Li ,  Fang Liang ,  Lei Liu ,  Yuan Mi ,  Yao-chang Xu ,  Guoliang Xun ,  Xiaoxia Yan ,  Zhengtian Yu ,  Ji Yue Zhang

发明人： Miao Dai ,  Xingnian Fu ,  Feng He ,  Lei Jiang ,  Yue Li ,  Fang Liang ,  Lei Liu ,  Yuan Mi ,  Yao-chang Xu ,  Guoliang Xun ,  Xiaoxia Yan ,  Zhengtian Yu ,  Ji Yue Zhang

IPC分类号： C07D487/04 ,  A61K31/5025 ,  A61P35/00

CPC分类号： C07D471/04

摘要： The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).

公开(公告)号：US20130324526A1

公开(公告)日：2013-12-05

申请号：US13984429

申请日：2012-02-08

申请人： Feng He ,  Haibing Deng ,  Xingnian Fu ,  Haibing Guo ,  Yuan Mi ,  Xiaoxia Yan ,  Hongping Yu ,  Ji Yue (Jeff) Zhang

发明人： Feng He ,  Haibing Deng ,  Xingnian Fu ,  Haibing Guo ,  Yuan Mi ,  Xiaoxia Yan ,  Hongping Yu ,  Ji Yue (Jeff) Zhang

IPC分类号： C07D471/04 ,  A61K31/5377 ,  A61K45/06 ,  A61K31/5025

CPC分类号： C07D471/04 ,  A61K31/5025 ,  A61K31/5377 ,  A61K45/06 ,  C07D487/04

摘要： The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).

摘要翻译： 本发明涉及式（I）的化合物及其盐：其中取代基如说明书中所定义; 用于治疗人或动物体的式（I）化合物，特别是关于c-Met酪氨酸激酶介导的疾病或病症; 使用式（I）化合物制备用于治疗这些疾病的药物; 包含式（I）化合物，任选在组合配偶体存在下的药物组合物，以及制备式（I）化合物的方法。